Literature DB >> 20152552

GARS axonopathy: not every neuron's cup of tRNA.

William W Motley1, Kevin Talbot, Kenneth H Fischbeck.   

Abstract

Charcot-Marie-Tooth disease type 2D, a hereditary axonal neuropathy, is caused by mutations in glycyl-tRNA synthetase (GARS). The mutations are distributed throughout the protein in multiple functional domains. In biochemical and cell culture experiments, some mutant forms of GARS have been indistinguishable from wild-type protein, suggesting that these in vitro tests might not adequately assess the aberrant activity responsible for axonal degeneration. Recently, mouse and fly models have offered new insights into the disease mechanism. There are still gaps in our understanding of how mutations in a ubiquitously expressed component of the translation machinery result in axonal neuropathy. Here, we review recent reports, weigh the evidence for and against possible mechanisms and suggest areas of focus for future work. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152552      PMCID: PMC2822721          DOI: 10.1016/j.tins.2009.11.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  38 in total

1.  Axonal protein synthesis provides a mechanism for localized regulation at an intermediate target.

Authors:  Perry A Brittis; Qiang Lu; John G Flanagan
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

3.  SOD1 aggregates in ALS: cause, correlate or consequence?

Authors:  R H Brown
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

4.  Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D).

Authors:  V Ionasescu; C Searby; V C Sheffield; T Roklina; D Nishimura; R Ionasescu
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

5.  Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.

Authors:  Kumaraswamy Sivakumar; Theodoros Kyriakides; Imke Puls; Garth A Nicholson; Benoît Funalot; Anthony Antonellis; Nyamkhishig Sambuughin; Kyproula Christodoulou; John L Beggs; Eleni Zamba-Papanicolaou; Victor Ionasescu; Marinos C Dalakas; Eric D Green; Kenneth H Fischbeck; Lev G Goldfarb
Journal:  Brain       Date:  2005-07-13       Impact factor: 13.501

6.  Mutant dynactin in motor neuron disease.

Authors:  Imke Puls; Catherine Jonnakuty; Bernadette H LaMonte; Erika L F Holzbaur; Mariko Tokito; Eric Mann; Mary Kay Floeter; Kimberly Bidus; Dennis Drayna; Shin J Oh; Robert H Brown; Christy L Ludlow; Kenneth H Fischbeck
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

7.  Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p.

Authors:  K Christodoulou; T Kyriakides; A H Hristova; D M Georgiou; L Kalaydjieva; B Yshpekova; T Ivanova; J L Weber; L T Middleton
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

8.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.

Authors:  Albena Jordanova; Joy Irobi; Florian P Thomas; Patrick Van Dijck; Kris Meerschaert; Maarten Dewil; Ines Dierick; An Jacobs; Els De Vriendt; Velina Guergueltcheva; Chitharanjan V Rao; Ivailo Tournev; Francisco A A Gondim; Marc D'Hooghe; Veerle Van Gerwen; Patrick Callaerts; Ludo Van Den Bosch; Jean-Pièrre Timmermans; Wim Robberecht; Jan Gettemans; Johan M Thevelein; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Nat Genet       Date:  2006-01-22       Impact factor: 38.330

9.  Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila.

Authors:  D D Hurd; W M Saxton
Journal:  Genetics       Date:  1996-11       Impact factor: 4.562

10.  Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15.

Authors:  N Sambuughin; K Sivakumar; B Selenge; H S Lee; D Friedlich; D Baasanjav; M C Dalakas; L G Goldfarb
Journal:  J Neurol Sci       Date:  1998-11-26       Impact factor: 3.181

View more
  41 in total

1.  A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).

Authors:  Ah Jung Seo; Youn Ho Shin; Seo Jin Lee; Doyeun Kim; Byung Sun Park; Sunghoon Kim; Kyu Ha Choi; Na Young Jeong; Chan Park; Ji-Yeon Jang; Youngbuhm Huh; Junyang Jung
Journal:  J Mol Histol       Date:  2013-08-30       Impact factor: 2.611

2.  Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening.

Authors:  Weiwei He; Hui-Min Zhang; Yeeting E Chong; Min Guo; Alan G Marshall; Xiang-Lei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

3.  Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis.

Authors:  Min Chul Park; Taehee Kang; Da Jin; Jung Min Han; Sang Bum Kim; Yun Jung Park; Kiwon Cho; Young Woo Park; Min Guo; Weiwei He; Xiang-Lei Yang; Paul Schimmel; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-15       Impact factor: 11.205

Review 4.  Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.

Authors:  Stephanie N Oprescu; Laurie B Griffin; Asim A Beg; Anthony Antonellis
Journal:  Methods       Date:  2016-11-20       Impact factor: 3.608

5.  Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy.

Authors:  Jamie A Abbott; Rebecca Meyer-Schuman; Vincenzo Lupo; Shawna Feely; Inès Mademan; Stephanie N Oprescu; Laurie B Griffin; M Antonia Alberti; Carlos Casasnovas; Sharon Aharoni; Lina Basel-Vanagaite; Stephan Züchner; Peter De Jonghe; Jonathan Baets; Michael E Shy; Carmen Espinós; Borries Demeler; Anthony Antonellis; Christopher Francklyn
Journal:  Hum Mutat       Date:  2017-12-26       Impact factor: 4.878

6.  Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy.

Authors:  David Blocquel; Sheng Li; Na Wei; Herwin Daub; Mathew Sajish; Maria-Luise Erfurth; Grace Kooi; Jiadong Zhou; Ge Bai; Paul Schimmel; Albena Jordanova; Xiang-Lei Yang
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

7.  Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.

Authors:  Dana Safka Brozkova; Tine Deconinck; Laurie Beth Griffin; Andreas Ferbert; Jana Haberlova; Radim Mazanec; Petra Lassuthova; Christian Roth; Thanita Pilunthanakul; Bernd Rautenstrauss; Andreas R Janecke; Petra Zavadakova; Roman Chrast; Carlo Rivolta; Stephan Zuchner; Anthony Antonellis; Asim A Beg; Peter De Jonghe; Jan Senderek; Pavel Seeman; Jonathan Baets
Journal:  Brain       Date:  2015-06-13       Impact factor: 13.501

Review 8.  Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.

Authors:  Na Wei; Qian Zhang; Xiang-Lei Yang
Journal:  J Biol Chem       Date:  2019-01-14       Impact factor: 5.157

9.  CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.

Authors:  Biljana Ermanoska; William W Motley; Ricardo Leitão-Gonçalves; Bob Asselbergh; LaTasha H Lee; Peter De Rijk; Kristel Sleegers; Tinne Ooms; Tanja A Godenschwege; Vincent Timmerman; Kenneth H Fischbeck; Albena Jordanova
Journal:  Neurobiol Dis       Date:  2014-05-05       Impact factor: 5.996

10.  Elaborate uORF/IRES features control expression and localization of human glycyl-tRNA synthetase.

Authors:  Jana Alexandrova; Caroline Paulus; Joëlle Rudinger-Thirion; Fabrice Jossinet; Magali Frugier
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.